Experts outline AE risks—including ICANS, CRS, HLH—as T-cell engager use expands, highlighting the crucial role of nurses and APPs.
Al-Ola Abdallah, MD
Advertisement
Al-Ola Abdallah, MD, a myeloma physician and associate professor director of plasma cell disorder program at the University of Kansas Medical Center.
Articles by Al-Ola Abdallah, MD
Advertisement
Latest Updated Articles
Nurses, APPs Key to AE Management as T-Cell Engagers Move Into Solid TumorsPublished: August 10th 2025 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Race Identified as Prognostic Indicator in Black Patients With AML
2
Families of Children With ALL Face Extreme Financial Toxicity
3
Fixed-Duration Venetoclax Regimens Yield Noninferior CLL PFS to Ibrutinib
4
FDA Approves Liso-Cel in Pretreated R/R Marginal Zone Lymphoma
5
